126 related articles for article (PubMed ID: 35102572)
1. Neurodevelopmental toxicity of pyrazinamide to larval zebrafish and the restoration after intoxication withdrawal.
Wang X; Wu F; Zou H; Yang Y; Chen G; Liu K; Zhang Y; Liu L
J Appl Toxicol; 2022 Jul; 42(7):1276-1286. PubMed ID: 35102572
[TBL] [Abstract][Full Text] [Related]
2. Involvement of dopamine signaling pathway in neurodevelopmental toxicity induced by isoniazid in zebrafish.
Liu L; Wu FY; Zhu CY; Zou HY; Kong RQ; Ma YK; Su D; Song GQ; Zhang Y; Liu KC
Chemosphere; 2021 Feb; 265():129109. PubMed ID: 33280847
[TBL] [Abstract][Full Text] [Related]
3. Liver Fatty Acid Binding Protein Deficiency Provokes Oxidative Stress, Inflammation, and Apoptosis-Mediated Hepatotoxicity Induced by Pyrazinamide in Zebrafish Larvae.
Zhang Y; Liu K; Hassan HM; Guo H; Ding P; Han L; He Q; Chen W; Hsiao CD; Zhang L; Jiang Z
Antimicrob Agents Chemother; 2016 Dec; 60(12):7347-7356. PubMed ID: 27697757
[TBL] [Abstract][Full Text] [Related]
4. Isoniazid and its toxic metabolite hydrazine induce in vitro pyrazinamide toxicity.
Tostmann A; Boeree MJ; Peters WH; Roelofs HM; Aarnoutse RE; van der Ven AJ; Dekhuijzen PN
Int J Antimicrob Agents; 2008 Jun; 31(6):577-80. PubMed ID: 18358703
[TBL] [Abstract][Full Text] [Related]
5. An Evaluation of the In Vitro Roles and Mechanisms of Silibinin in Reducing Pyrazinamide- and Isoniazid-Induced Hepatocellular Damage.
Goh ZH; Tee JK; Ho HK
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32466226
[TBL] [Abstract][Full Text] [Related]
6. Near-infrared molecular sensor for visualizing and tracking ONOO
Liu X; Ma Y; Liu Y; Li Q; Zhang H; Fu S; Chen S; Li H; Li S; Hou P
Anal Bioanal Chem; 2023 Dec; 415(29-30):7187-7196. PubMed ID: 37801118
[TBL] [Abstract][Full Text] [Related]
7. Oxidative stress-mediated developmental toxicity induced by isoniazide in zebrafish embryos and larvae.
Zou Y; Zhang Y; Han L; He Q; Hou H; Han J; Wang X; Li C; Cen J; Liu K
J Appl Toxicol; 2017 Jul; 37(7):842-852. PubMed ID: 28139008
[TBL] [Abstract][Full Text] [Related]
8. Paradoxical effect of isoniazid on the activity of rifampin-pyrazinamide combination in a mouse model of tuberculosis.
Almeida D; Nuermberger E; Tasneen R; Rosenthal I; Tyagi S; Williams K; Peloquin C; Grosset J
Antimicrob Agents Chemother; 2009 Oct; 53(10):4178-84. PubMed ID: 19620331
[TBL] [Abstract][Full Text] [Related]
9. Adverse effects of anti-tuberculosis drugs on HepG2 cell bioenergetics.
Elmorsy E; Attalla SM; Fikry E; Kocon A; Turner R; Christie D; Warren A; Nwidu LL; Carter WG
Hum Exp Toxicol; 2017 Jun; 36(6):616-625. PubMed ID: 27461009
[TBL] [Abstract][Full Text] [Related]
10. Deleterious effects of 28-day oral co-administration of first-line anti-TB drugs on spleen, blood and bone marrow chromosomes in normal rat.
Sharma R; Sharma VL
Drug Chem Toxicol; 2017 Apr; 40(2):154-163. PubMed ID: 27250504
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of isoniazid-induced hepatotoxicity in zebrafish larvae: Activation of ROS-mediated ERS, apoptosis and the Nrf2 pathway.
Jia ZL; Cen J; Wang JB; Zhang F; Xia Q; Wang X; Chen XQ; Wang RC; Hsiao CD; Liu KC; Zhang Y
Chemosphere; 2019 Jul; 227():541-550. PubMed ID: 31004821
[TBL] [Abstract][Full Text] [Related]
12. Exposure of particulate matter (PM
Zhang Y; Jia Z; Rajendran RS; Zhu C; Wang X; Liu K; Cen J
Neurotoxicology; 2021 Dec; 87():208-218. PubMed ID: 34678400
[TBL] [Abstract][Full Text] [Related]
13. Neurotoxicity of tetrabromobisphenol A and SiO2 nanoparticle co-exposure in zebrafish and barrier function of the embryonic chorion.
Zhu B; Lei L; Fu K; Zhao S; Hua J; Yang L; Han J; Li R; Zhou B
Sci Total Environ; 2022 Nov; 845():157364. PubMed ID: 35843329
[TBL] [Abstract][Full Text] [Related]
14. The effect of growth rate on pyrazinamide activity in Mycobacterium tuberculosis - insights for early bactericidal activity?
Pullan ST; Allnutt JC; Devine R; Hatch KA; Jeeves RE; Hendon-Dunn CL; Marsh PD; Bacon J
BMC Infect Dis; 2016 May; 16():205. PubMed ID: 27184366
[TBL] [Abstract][Full Text] [Related]
15. Terminalia chebula (fruit) prevents liver toxicity caused by sub-chronic administration of rifampicin, isoniazid and pyrazinamide in combination.
Tasduq SA; Singh K; Satti NK; Gupta DK; Suri KA; Johri RK
Hum Exp Toxicol; 2006 Mar; 25(3):111-8. PubMed ID: 16634329
[TBL] [Abstract][Full Text] [Related]
16. [Prevalence and transmission of pyrazinamide-resistant
Liu BB; Hu PL; Chen ZH; Yi SL; Zhang XP; Tan YH
Zhonghua Jie He He Hu Xi Za Zhi; 2022 Jul; 45(7):677-685. PubMed ID: 35768376
[No Abstract] [Full Text] [Related]
17. Anti-tuberculosis drug concentrations in tuberculosis patients with and without diabetes mellitus.
Kumar AK; Chandrasekaran V; Kannan T; Murali AL; Lavanya J; Sudha V; Swaminathan S; Ramachandran G
Eur J Clin Pharmacol; 2017 Jan; 73(1):65-70. PubMed ID: 27651240
[TBL] [Abstract][Full Text] [Related]
18. Bile acids, lipid and purine metabolism involved in hepatotoxicity of first-line anti-tuberculosis drugs.
Liu L; Li X; Huang C; Bian Y; Liu X; Cao J; Qu W; Miao L
Expert Opin Drug Metab Toxicol; 2020 Jun; 16(6):527-537. PubMed ID: 32436768
[TBL] [Abstract][Full Text] [Related]
19. Pyrazinamide induced hepatic injury in rats through inhibiting the PPARα pathway.
Zhang Y; Guo H; Hassan HM; Ding PP; Su Y; Song Y; Wang T; Sun L; Zhang L; Jiang Z
J Appl Toxicol; 2016 Dec; 36(12):1579-1590. PubMed ID: 27071702
[TBL] [Abstract][Full Text] [Related]
20. Antagonism between isoniazid and the combination pyrazinamide-rifampin against tuberculosis infection in mice.
Grosset J; Truffot-Pernot C; Lacroix C; Ji B
Antimicrob Agents Chemother; 1992 Mar; 36(3):548-51. PubMed ID: 1622164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
